ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.

During a live event, Jeffrey V. Matous, MD, discussed bispecific antibody treatment efficacy and safety in advanced multiple ...

A global study led by researchers at the School of Clinical Sciences at Monash Health, Monash University, has found that ...

Neuronetics Inc. (NASDAQ:STIM) is one of the best-performing NASDAQ stocks according to analysts. On June 10, Neuronetics ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

Logistics and sample handling are critical components of central lab services, and issues with these processes can limit the growth of the central lab market. PORTLAND, OR, UNITED STATES, July 4, 2025 ...

Najpierw wprowadzenie podatku akcyzowego na saszetki nikotynowe, potem propozycja przepisów, które zmierzają do wycofania tych produktów z rynku – przedstawiciele środowisk ...

The Food and Drug Administration will issue new guidelines requiring stiffer clinical trials prior to the approval of new COVID boosters.

Design A cross-sectional analysis of baseline data from the French nationwide ‘Elderly Appropriate Treatment in Primary Care’ trial. Setting Primary care ... elderly patients in primary care. The ...

They have long been left out of clinical trials, including recent trials of lecanemab and donanemab, the first drugs against Alzheimer’s that seem to slow the progress of the disease.

Corvus Pharmaceuticals announced new interim results from its Phase 1 clinical trial of soquelitinib in patients with moderate to severe atopic dermatitis. The randomized, double-blind, placebo ...